OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 127 filers reported holding OCULAR THERAPEUTIX INC in Q1 2023. The put-call ratio across all filers is 0.49 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $3 | -25.0% | 407 | 0.0% | 0.00% | – |
| Q1 2024 | $4 | +300.0% | 407 | +55.3% | 0.00% | – |
| Q4 2023 | $1 | 0.0% | 262 | 0.0% | 0.00% | – |
| Q3 2023 | $1 | 0.0% | 262 | 0.0% | 0.00% | – |
| Q2 2023 | $1 | 0.0% | 262 | 0.0% | 0.00% | – |
| Q1 2023 | $1 | 0.0% | 262 | 0.0% | 0.00% | – |
| Q4 2022 | $1 | -99.9% | 262 | 0.0% | 0.00% | – |
| Q3 2022 | $1,000 | 0.0% | 262 | 0.0% | 0.00% | – |
| Q2 2022 | $1,000 | 0.0% | 262 | 0.0% | 0.00% | – |
| Q1 2022 | $1,000 | -50.0% | 262 | 0.0% | 0.00% | – |
| Q4 2021 | $2,000 | -33.3% | 262 | 0.0% | 0.00% | – |
| Q3 2021 | $3,000 | +50.0% | 262 | +95.5% | 0.00% | – |
| Q2 2021 | $2,000 | 0.0% | 134 | 0.0% | 0.00% | – |
| Q1 2021 | $2,000 | -33.3% | 134 | 0.0% | 0.00% | – |
| Q4 2020 | $3,000 | +200.0% | 134 | -50.0% | 0.00% | – |
| Q3 2019 | $1,000 | 0.0% | 268 | 0.0% | 0.00% | – |
| Q2 2019 | $1,000 | 0.0% | 268 | 0.0% | 0.00% | – |
| Q1 2019 | $1,000 | – | 268 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SUMMER ROAD LLC | 3,784,850 | $15,064,000 | 62.56% |
| Versant Venture Management, LLC | 2,215,384 | $8,817,228,000 | 4.36% |
| SV Health Investors, LLC | 628,236 | $2,500,000 | 1.54% |
| DELTEC ASSET MANAGEMENT LLC | 724,747 | $2,885,000 | 0.80% |
| Endurant Capital Management LP | 232,727 | $926,000 | 0.49% |
| NOTTINGHAM ADVISORS, INC. | 146,946 | $1,011,000 | 0.15% |
| JGP Global Gestao de Recursos Ltda. | 12,568 | $50,000 | 0.06% |
| Man Group plc | 1,187,508 | $4,726,000 | 0.02% |
| Dynamic Technology Lab Private Ltd | 21,077 | $84,000 | 0.02% |
| NewEdge Advisors, LLC | 36,250 | $144,000 | 0.01% |